M&A

Eddingpharm reverse-merger ‘breakthrough’ for Hong Kong stock exchange Eddingpharm reverse-merger ‘breakthrough’ for Hong Kong stock exchange

Eddingpharm will take over Genor Biopharma in a reverse merger that reduces the holdings of current shareholders to 22% of the expanded company.

byRichard Daverman

Oct 31, 2024

|

1 Min Read

Alzheimer's disease written in blocks

AbbVie forks out $1.4bn to buy Alzheimer’s therapy developer Aliada AbbVie forks out $1.4bn to buy Aliada

byMillie Nelson

Oct 29, 2024

1 Min Read

Wooden block with people icons

Want to be a partner of choice? Distinguish yourself in the space Want to be a partner of choice? Distinguish yourself in the space

byMillie Nelson

Sep 25, 2024

1 Min Read

To be truly great you need to partner, says J&J To be truly great you need to partner, says J&J

byMillie Nelson

Sep 25, 2024

1 Min Read

Christmas present

RayzeBio: A Christmas to remember RayzeBio: A Christmas to remember

byMillie Nelson

Sep 25, 2024

1 Min Read

People making business deals

Prometheus and Merck: Under the bonnet of the largest pre-Phase III M&A deal Under the bonnet of the largest pre-Phase III M&A deal

byMillie Nelson

Sep 25, 2024

1 Min Read

Top five Asia biopharma deals: August 2024

Asia biopharma deals: August 2024

byRichard Daverman

Subscribe to Our Newsletters

Stay updated and receive your insights for life sciences investment, innovation and partnering directly in your inbox.